Secular Trends of Hospitalization With Vancomycin-Resistant Enterococcus Infection in the United States, 2000-2006

被引：87

作者：

Ramsey, Andrew M. ^{[2
]}

Zilberberg, Marya D. ^{[1
,2
]}

机构：

[1] EviMed Res Grp, Goshen, MA 01032 USA

[2] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA

来源：

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2009年 / 30卷 / 02期

关键词：

CLOSTRIDIUM-DIFFICILE; STAPHYLOCOCCUS-AUREUS;

D O I：

10.1086/593956

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Although the incidence of hospitalizations with infection due to vancomycin-resistant pathogens in the United States remained stable during 2000-2003, it increased from 4.60 to 9.48 hospitalizations per 100,000 population during 2003-2006. Hospitalizations with infection due to vancomycin-resistant pathogens also increased as a proportion of all US hospitalizations, from 3.16 to 6.51 hospitalizations with VRE infection per 10,000 total hospitalizations during 2003-2006. The number of hospitalizations with infection due to vancomycin-resistant pathogens is increasing in the United States. Because infection due to vancomycin-resistant organisms is associated with poor outcomes, the epidemiology of this trend needs further exploration.

引用

页码：184 / 186

页数：3

共 50 条

[41] Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review
de Bruin, Monique A.
Riley, Lee W.
BMC INFECTIOUS DISEASES, 2007, 7 (1)
[42] Secular Trends in Nosocomial Vancomycin-Resistant Enterococcal Bloodstream Infections Among United States Veterans Affairs Hospitals, Fiscal Years 2004 through 2014
Britt, Nicholas S.
Potter, Emily M.
McKinnell, James A.
Patel, Nimish
Battersby, Sarah E.
Steed, Molly E.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2017, 38 (09): : 1114 - 1116
[43] Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review
Monique A de Bruin
Lee W Riley
BMC Infectious Diseases, 7
[44] Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment
Di Cecco, Caterina
Monticelli, Jacopo
Di Bella, Stefano
Di Maso, Vittorio
Luzzati, Roberto
JOURNAL OF CHEMOTHERAPY, 2024, 36 (01) : 31 - 34
[45] Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks
Tedim, Ana P.
Lanza, Val F.
Rodriguez, Concepcion M.
Freitas, Ana R.
Novais, Carla
Peixe, Luisa
Baquero, Fernando
Coque, Teresa M.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (11) : 2757 - 2764
[46] Outcomes of Invasive Infection due to Vancomycin-Resistant Enterococcus faecium during a Recent Outbreak
Theilacker, C.
Jonas, D.
Huebner, J.
Bertz, H.
Kern, W. V.
INFECTION, 2009, 37 (06) : 540 - 543
[47] Clinical and microbiological characteristics of vancomycin-resistant Enterococcus faecium bloodstream infection in Central Taiwan
Chen, Chang-Hua
Lin, Li-Chen
Chang, Yu-Jun
Chang, Chih-Yen
MEDICINE, 2017, 96 (49)
[48] Vancomycin-resistant Enterococcus faecium and the emergence of new sequence types associated with hospital infection
O'Toole, Ronan F.
Leong, Kelvin W. C.
Cumming, Vanessa
Van Hal, Sebastiaan J.
RESEARCH IN MICROBIOLOGY, 2023, 174 (04)
[49] Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium
Pai, MP
Rodvold, KA
Schreckenberger, PC
Gonzales, RD
Petrolatti, JM
Quinn, JP
CLINICAL INFECTIOUS DISEASES, 2002, 35 (10) : 1269 - 1272
[50] Evolution of vancomycin-resistant Enterococcus faecium during colonization and infection in immunocompromised pediatric patients
Chilambi, Gayatri Shankar
Nordstrom, Hayley R.
Evans, Daniel R.
Ferrolino, Jose A.
Hayden, Randall T.
Maron, Gabriela M.
Vo, Anh N.
Gilmore, Michael S.
Wolf, Joshua
Rosch, Jason W.
Van Tyne, Daria
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (21) : 11703 - 11714

← 1 2 3 4 5 →